Role of DMARD Naïve Period in the Development of Severe Rheumatoid Arthritis.
Cross-sectional study
DMARD naïve period
Erosions
India
Rheumatoid arthritis
Journal
Indian journal of orthopaedics
ISSN: 0019-5413
Titre abrégé: Indian J Orthop
Pays: Switzerland
ID NLM: 0137736
Informations de publication
Date de publication:
Jul 2020
Jul 2020
Historique:
received:
29
12
2019
accepted:
21
02
2020
entrez:
19
6
2020
pubmed:
19
6
2020
medline:
19
6
2020
Statut:
epublish
Résumé
Rheumatoid arthritis (RA) is a symmetric poly-arthritis predominantly affecting the small synovial joints, although any synovial joint can be involved. The underlying cause is not known; however, predilection for the disease is impacted by genetic and environmental factors. Several factors predict disease severity in RA including development of erosions, female sex and duration of disease. This study evaluates the role of disease duration, early initiation of disease modifying anti-rheumatic drugs (DMARDs) and auto-antibodies like rheumatoid factor in predicting erosive disease in Indian patients with rheumatoid arthritis. A 2-year hospital-based cross-sectional observational study was conducted in the Department of Medicine in a tertiary care centre in Kumaon region of Uttarakhand in northern India. 260 patients diagnosed with RA on the basis of 2010 ACR/EULAR criteria were included. A total of 135 patients had erosive disease, with DMARD naive median period of 3 years compared to 125 patients with non-erosive disease, with DMARD naive median period of 2 years. On the basis of this data and after evaluation for radiographic erosions, it was found that a longer DMARD naive period predicts higher odds of developing erosive disease. Early diagnosis of rheumatoid arthritis and initiation of DMARDs is crucial in increasing quality of life and preventing severe disease with deformities, erosive changes and extra-articular manifestations.
Sections du résumé
BACKGROUND
BACKGROUND
Rheumatoid arthritis (RA) is a symmetric poly-arthritis predominantly affecting the small synovial joints, although any synovial joint can be involved. The underlying cause is not known; however, predilection for the disease is impacted by genetic and environmental factors. Several factors predict disease severity in RA including development of erosions, female sex and duration of disease. This study evaluates the role of disease duration, early initiation of disease modifying anti-rheumatic drugs (DMARDs) and auto-antibodies like rheumatoid factor in predicting erosive disease in Indian patients with rheumatoid arthritis.
METHODS
METHODS
A 2-year hospital-based cross-sectional observational study was conducted in the Department of Medicine in a tertiary care centre in Kumaon region of Uttarakhand in northern India. 260 patients diagnosed with RA on the basis of 2010 ACR/EULAR criteria were included.
RESULTS
RESULTS
A total of 135 patients had erosive disease, with DMARD naive median period of 3 years compared to 125 patients with non-erosive disease, with DMARD naive median period of 2 years. On the basis of this data and after evaluation for radiographic erosions, it was found that a longer DMARD naive period predicts higher odds of developing erosive disease.
CONCLUSION
CONCLUSIONS
Early diagnosis of rheumatoid arthritis and initiation of DMARDs is crucial in increasing quality of life and preventing severe disease with deformities, erosive changes and extra-articular manifestations.
Identifiants
pubmed: 32549967
doi: 10.1007/s43465-020-00077-8
pii: 77
pmc: PMC7270310
doi:
Types de publication
Journal Article
Langues
eng
Pagination
513-517Informations de copyright
© Indian Orthopaedics Association 2020.
Déclaration de conflit d'intérêts
Conflict of interestMadhav Bahadur, Paramjeet Singh, Vivekanand Satyawali and Arun Joshi declare that they have no conflicts of interest.
Références
Indian J Med Res. 2006 Dec;124(6):689-96
pubmed: 17287557
Am J Med. 1956 Dec;21(6):888-92
pubmed: 13372565
Rheumatol Int. 1993;13(4):131-4
pubmed: 8310203
Br Med J. 1973 Apr 14;2(5858):96-100
pubmed: 4700332
Int J Rheum Dis. 2016 May;19(5):440-51
pubmed: 26171649
Int J Rheum Dis. 2015 May;18(4):433-8
pubmed: 26010598
Rheumatology (Oxford). 2004 Jul;43(7):906-14
pubmed: 15113999
Natl Med J India. 2007 Sep-Oct;20(5):236-9
pubmed: 18254519
Curr Rheumatol Rep. 2012 Oct;14(5):472-80
pubmed: 22773387
Rheumatol Int. 2009 Feb;29(4):377-81
pubmed: 18795293
Am J Med. 2001 Oct 15;111(6):446-51
pubmed: 11690569
J Rheumatol. 1993 Aug;20(8):1288-96
pubmed: 8230007
Arthritis Rheum. 1984 Aug;27(8):864-72
pubmed: 6431998
Ann Rheum Dis. 2010 Sep;69(9):1580-8
pubmed: 20699241